## 2 Background
\begin{table}
\begin{tabular}{l l l l l l} \hline \hline
**Paper** & **Outcome** & **Data** & & **Method** & **Metric** \\ \hline \multirow{8}{*}{[PERSON], 2004 (PRESTO-1, PRESTO-2) [11, 20]} & \multirow{8}{*}{SR} & Cohort name & PRESTO trial & \\ \cline{3-5}  & & \# Patients & 1312 & \\ \cline{3-5}  & & \& Ethnicity & Heterogeneous worldwide, 224 hospitals & Multi-class LR & AUC-ROC \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 45.4\% & \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & BMS & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic, procedural, and follow-up angiographic information & \\ \hline \multirow{8}{*}{[PERSON], 2008 (Framingham Risk Score) [12]} & \multirow{8}{*}{CAD} & Cohort name & Framingham study & \\ \cline{3-5}  & & \# Patients & 8491 & Cox proportional-hazards & C-index \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Participants from one city (Framingham, Massachusetts) & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic and socioeconomic, CAD phenotype (incl. genetic biomarkers), & \\ \cline{3-5}  & & \multicolumn{1}{l}{procedural, and follow-up angiographic information} & \\ \hline \multirow{8}{*}{[PERSON], 2010 (EVENT) [21]} & \multirow{8}{*}{TLR} & Cohort name & EVENT registry & \\ \cline{3-5}  & & \# Patients & 5863 & \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Heterogeneous from USA & \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 4.1\% & \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & DES & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Demographic, clinical, and treatment features & \\ \hline \multirow{8}{*}{Casseee, 2014 [22]} & \multirow{8}{*}{SR} & \# Patients & 10,004 & \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Homogeneous German, two hospitals & \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 26.4\% & \(X^{2}\) test & \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & BMS or 1 st/2 nd-generation DES & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic, procedural, and follow-up angiographic information & \\ \hline \multirow{8}{*}{Alaa, 2019 [16]} & \multirow{8}{*}{CAD} & Cohort name & UK Biobank & \\ \cline{3-5}  & & \# Patients & 423,604 & \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Homogeneous from UK, 22 hospitals & SCL & AUC-ROC \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 1.1\% & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographics, procedural, and follow-up angiographic information & \\ \hline \multirow{8}{*}{Kongistein, 2019 [15]} & \multirow{8}{*}{TLF} & Cohort name & Pool from six randomized controlled trials & \\ \cline{3-5}  & & \# Patients & 10,072 & \\ \cline{3-5}  & & Ethnicity & Heterogeneous, worldwide & Cox proportional-hazards & \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 10.1\% & regression & C-index \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & Contemporary DES & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic, procedural, and follow-up angiographic information & \\ \hline \multirow{8}{*}{Anadol, 2020 [14]} & \multirow{8}{*}{TLF} & Cohort name & MICAT project & \\ \cline{3-5}  & & \# Patients & 512 & \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Heterogeneous, worldwide (14 countries) & Cox proportional-hazards & \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 17.9\% & & \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & \multicolumn{1}{l}{BRS (Abbott Vascular)} & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic, procedural, and follow-up angiographic information & \\ \hline \multirow{8}{*}{Sampedo-Gómez, 2020 [17]} & \multirow{8}{*}{SR} & Cohort name & GRACIA-3 study & \\ \cline{3-5}  & & \# Patients & 263 & \\ \cline{3-5}  & & \multicolumn{1}{l}{Ethnicity} & Homogeneous Spanish & \\ \cline{3-5}  & & \multicolumn{1}{l}{Outcome ratio} & 8.9\% & \\ \cline{3-5}  & & \multicolumn{1}{l}{Medical device} & DES & \\ \cline{3-5}  & & \multicolumn{1}{l}{Features} & Baseline demographic, procedural, and follow-up angiographic information & \\ \hline \hline \end{tabular}
\end{table}